tradingkey.logo
tradingkey.logo
Search

Ocugen Announces Rare Pediatric Disease Designation Granted For Ocu410st—Modifier Gene Therapy For The Treatment Of Stargardt Disease

ReutersMay 27, 2025 12:06 PM
facebooktwitterlinkedin

- Ocugen Inc OCGN.O:

  • OCUGEN ANNOUNCES RARE PEDIATRIC DISEASE DESIGNATION GRANTED FOR OCU410ST—MODIFIER GENE THERAPY FOR THE TREATMENT OF STARGARDT DISEASE

  • OCUGEN INC: PLANS TO INITIATE PHASE 2/3 PIVOTAL CONFIRMATORY TRIAL IN FEW WEEKS WITH TARGET BLA IN 2027

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI